References
- Banner W, Baxter L, Akins J. Envenomations due to pygmy rattlesnakes in Oklahoma: treatment options. J Med Toxicol. 2008;4:44–45.
- King AM, Williams SC, Menke NB, et al. Pygmy rattlesnake envenomation treated with crotalidae polyvalent immune fab antivenom. Toxicon. 2012;60:1287–1289.
- Miller AD, Young MC, DeMott MC, et al. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab. Pediatr Emerg Care. 2010;26:576–582.
- Sánchez E, Galán J, Perez J, et al. The efficacy of two antivenoms against the venom of North American snakes. Toxicon. 2003;41:357–365.
- Pizon AF, Riley BD, LoVecchio F, et al. Safety and efficacy of Crotalidae polyvalent immune Fab in pediatric crotaline envenomations. Acad Emerg Med. 2007;14:373–376.
- Johnson PN, McGoodwin L, Banner W Jr. Uitilization of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children. Emerg Med J. 2008;25:793–798.
- Antivipmyn TRI® package insert. 2003.
- Bush S, Seifert S, Oakes J, et al. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American Rattlesnake bite patients. Toxicon. 2013;69:29–37.